Explore

Trendline Trendline
Anthropic Acquires Coefficient Bio to Expand AI in Life Sciences

Anthropic Acquires Coefficient Bio to Expand AI in Life Sciences

Anthropic Acquires Coefficient Bio to Expand AI in Life Sciences
Trendline Trendline
AI Revolutionizes Biotech Industry Amidst IT Sector Layoffs

AI Revolutionizes Biotech Industry Amidst IT Sector Layoffs

AI Revolutionizes Biotech Industry Amidst IT Sector Layoffs
Trendline Trendline
Augmented Intelligence Revolutionizes Biopharma Innovation Amidst Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amidst Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amidst Investment Challenges
Trendline Trendline
OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning
Trendline Trendline
Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges
Trendline Trendline
API's Lean Derisking Strategy Aims to Streamline Drug Development

API's Lean Derisking Strategy Aims to Streamline Drug Development

API's Lean Derisking Strategy Aims to Streamline Drug Development
Reuters Reuters
Nvidia acquisition of SchedMD sparks worry among AI specialists about software access

Nvidia acquisition of SchedMD sparks worry among AI specialists about software access

By Max A.
Trendline Trendline
Anthropic CEO Dario Amodei's Controversial Leadership Sparks Investor Concerns

Anthropic CEO Dario Amodei's Controversial Leadership Sparks Investor Concerns

Anthropic CEO Dario Amodei's Controversial Leadership Sparks Investor Concerns
Trendline Trendline
Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery

Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery

Anthropic Acquires Biotech AI Startup Coefficient Bio for $400 Million, Expanding AI in Drug Discovery
Trendline Trendline
Silicon Valley's AI Self-Improvement Efforts Spark Industry Frenzy and Concerns

Silicon Valley's AI Self-Improvement Efforts Spark Industry Frenzy and Concerns

Silicon Valley's AI Self-Improvement Efforts Spark Industry Frenzy and Concerns
Trendline Trendline
Anthropic Ends Third-Party Access to Claude Models, Impacting Open-Source Tools

Anthropic Ends Third-Party Access to Claude Models, Impacting Open-Source Tools

Anthropic Ends Third-Party Access to Claude Models, Impacting Open-Source Tools
Trendline Trendline
xAI Cofounder Departures Raise Concerns Amid SpaceX IPO Plans

xAI Cofounder Departures Raise Concerns Amid SpaceX IPO Plans

xAI Cofounder Departures Raise Concerns Amid SpaceX IPO Plans